ReShape Lifesciences (US:RSLS)2021-12-18 06:09Market Overview - The virtual healthcare delivery market is projected to reach $95 billion worldwide by 2026, with $77 billion in the U S [27] - The bariatric surgical device market is projected to reach $2 8 billion worldwide by 2025, with $1 8 billion in the U S [27] - The global weight loss and obesity management market is expected to reach an estimated value of $300 billion with a CAGR of 6 70% from 2019-2026 [28] - Over 30% of the global population, or 2 5 billion people, are considered overweight or obese, with a projected increase to 50% by 2030 [27] Company Strategy & Products - The company targets 100% of the largest market segment (BMI 27-40+) with physician-led weight loss solutions [100] - The company operates a unique weight loss ecosystem that provides more revenue-producing pathways [102] - The company leverages a proprietary, reimbursed telehealth counseling platform as a key element of its patient engagement and retention strategy [102] - The company's virtual coaching program resulted in patients losing 7 7% of their total body weight, compared to 3 4% for those who didn't use virtual coaching [43] - The Lap-Band program has seen over 1 million devices safely implanted by 650+ physicians worldwide [47] Financial Performance - Q3 revenues were $3 7 million compared to $3 6 million in 2020, and 9-month revenues were $10 5 million compared to $8 1 million [92] - The company achieved a solid gross profit margin of approximately 70% in the U S [89] - The company completed a fund raise totaling $46 2 million on June 30 [91]